nivolumab
bms
[]
 final thoughts are a very good summary. consistently prognostic, but no evidence ctdna is predictive, no evidence you can change trajectory if positive, &amp; sensitivity remains a challenge that precludes us from de-selecting patients for treatment based on mrd negativity.
Med Onc,@CityofHope; VP Netwk Strategy AccessHope, Founder,@CancerGRACE; Web Ed,@JAMAOnc; Author/Ed, @UptoDate

Telemed/digital med fan. 
Disclosures @ website